What Ophthamed Pharma does

Ophthamed Pharma Corp. is a 100% Filipino-owned, FDA-registered distributor of ophthalmic pharmaceuticals, health supplements, and medical devices operating exclusively in the Philippines. Founded by professionals with over six decades of combined experience in healthcare, pharmaceuticals, and surgical instrumentation, the company is headquartered in Quezon City, Metro Manila. Its portfolio spans six product categories: premium health supplements (Macucaps Plus for ARMD, Diavision for diabetic retinopathy, Glaucomin for glaucoma), preservative-free dry eye care (Hylo line via Ursapharm's patented COMOD multi-dose system), a full line of prescription and OTC ophthalmic drops (antibiotics, steroids, NSAIDs, anti-glaucoma, anti-allergy, artificial tears), ophthalmic diagnostic instrumentation (Optomed Smartscope Pro), low vision aids (Eschenbach Optik), and ophthalmic surgical training models (Bioniko).

The company differentiates via licensed proprietary ingredients (Pycnogenol and Mirtogenol from Horphag, COMOD system from Ursapharm) and higher-purity formulations (Macucaps Plus at 90% Lutein purity versus 10-20% in competitors). Its go-to-market is sales-led and direct-to-consumer, operating through phone (+632 8366 7622) and email contact, with prescription products distributed via a healthcare professional network of ophthalmologists and optometrists. Pricing is quote-based and not publicly disclosed, with all products carrying verifiable Philippine FDA registration numbers, which the company actively promotes as an anti-counterfeit signal to Filipino patients.

Name

Ophthamed Pharma

Legal name

Ophthamed Pharma Corp.

Website

https://ophthamedpharma.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Ophthamed Pharma Corp. is a Philippine FDA-registered, 100% Filipino-owned distributor of ophthalmic pharmaceuticals, premium eye health supplements, dry eye care products, diagnostic devices, and surgical simulators, serving Filipino patients, ophthalmologists, and optometrists through international brand partnerships.

Ownership category

akta.pro rank

Product category

Ophthalmic Pharmaceuticals

NAICS

Ophthalmic Goods Merchant Wholesalers (423460), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Ophthalmic Goods (3851), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

akta.pro secondary industries

Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD), Health & Pharmacy Omnichannel (CRAFAEAK)

Keywords

• Ophthalmic pharmaceuticals
• Eye health supplements
• Dry eye care products
• Ophthalmic surgical instruments
• Low vision aids

Headquarters

HQ city

New Manila

HQ country

Philippines

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Products: Sale of FDA-registered ophthalmic pharmaceuticals including topical antibiotics, steroids, NSAIDs, anti-infectives, anti-allergy, anti-glaucoma drops, and artificial tears. Products require prescription for certain categories.
2. Health Supplements: Sale of premium eye health supplements including Macucaps Plus (ARMD), Diavision (Diabetic Retinopathy), and Glaucomin (Glaucoma support). Supplements contain branded ingredients like Pycnogenol and Mirtogenol.
3. Medical Devices & Instruments: Distribution of ophthalmic instrumentation including Smartscope Pro diagnostic device, Eschenbach Optik low vision aids, Bioniko surgical simulator models, and intra-ocular lenses and accessories.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Ophthamed Pharma Corp. is an FDA-registered, 100% Filipino-owned pharmaceutical distributor that sells ophthalmic pharmaceuticals (antibiotics, steroids, NSAIDs, anti-glaucoma, anti-allergy, and artificial tears), premium eye health supplements (Macucaps Plus for ARMD, Diavision for diabetic retinopathy, Glaucomin for glaucoma), preservative-free dry eye care products (Hylo line), and ophthalmic instrumentation and surgical training devices. The company distributes world-class products in the Philippines through direct sales, healthcare professional networks, and partnerships with international brands including Ursapharm, Horphag, Eschenbach Optik, Optomed, and Bioniko.

Product overview

Ophthamed Pharma Corp. is a Philippine FDA registered pharmaceutical and ophthalmic products distributor offering a portfolio of health supplements and medical devices. The core product lines include: Macucaps Plus and Diavision capsules (health supplements for ARMD and diabetic retinopathy respectively), Hylo Dry Eye Care products and general Ophthalmic Drops (prescription and over-the-counter eye drops), Glaucomin supplement, and surgical/instrumentation products including Smartscope Pro diagnostic devices, Eschenbach Optik low vision aids, Bioniko surgical simulator models, and intra-ocular lenses with accessories. All pharmaceutical products are registered with the Philippine FDA and distributed primarily in the Philippines.

Differentiator

Problem solved

Functional benefit

Products and services

• Macucaps Plus Capsules Premium health supplement for Age-Related Macular Degeneration (ARMD) containing 30mg of 90% purity Lutein, fortified with Zeaxanthin and Meso-zeaxanthin plus antioxidants (Selenium, Zinc, Vitamin E and C). Provides 20-45 times more Lutein per capsule than competing brands. For Filipino patients with macular degeneration.
• Diavision Capsules Premium eye health supplement for Diabetic Retinopathy formulated with genuine Pycnogenol from Horphag France. FDA registered with registration number FR4000002827016. For Filipino patients with diabetic retinopathy.
• Hylo Dry Eye Care Products Preservative-free dry eye care products manufactured by Ursapharm Germany, including Hylo-COMOD, Hylo-GEL, and Hylo-FRESH. Features patented COMOD multi-dose airless pump system with multiple safety check valves including anti-bacterial silver for sterility without preservatives, delivering 300 metered drops per bottle. For patients with dry eye conditions.
• Ophthalmic Drops Portfolio Complete line of FDA-registered eye drops including topical ophthalmic antibiotics, topical ophthalmic steroids, topical NSAIDs, ophthalmic combination anti-infectives/anti-inflammatory agents, artificial tears/dry eye preparations, anti-allergy, and anti-glaucoma medications. Prescription products available through ophthalmologists.
• Glaucomin Glaucoma support supplement containing genuine licensed Mirtogenol, a registered trademark of Horphag Corporation. Duly registered with the Philippine FDA. For Filipino patients with glaucoma.
• Smartscope Pro Ophthalmic instrumentation device for diagnostic and examination purposes, manufactured by Optomed (Finland). For ophthalmologists and eye care professionals.
• Eschenbach Optik Low Vision Products Low vision optical products and devices, including optical magnifiers and visual rehabilitation equipment, distributed by Ophthamed Pharma as the Eschenbach Optik brand representative in the Philippines. For patients with visual impairment.
• Bioniko Ophthalmic Surgical Simulator Models Ophthalmic surgical simulator models for training purposes, manufactured by Bioniko. For ophthalmology training and education institutions and professionals.
• Intra-ocular Lenses and Accessories Intra-ocular lenses and accessories for ophthalmic surgical procedures. For ophthalmic surgeons and surgical centers.

Quantifiable outcome

• Macucaps Plus provides 20-45x more Lutein per capsule compared to other brands at lower cost (27mg available Lutein vs. 0.3-1.2mg in competitors)
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• UrsapharmcoreTechnology or IntegrationGerman manufacturer of Hylo Dry Eye Care products featuring the patented COMOD multi-dose system. Products include HYLO-COMOD, HYLO-GEL, and HYLO-FRESH. Ursapharm provides ultra-high technology manufacturing in Germany with products registered as No.1 dry eye product in Germany. Ophthamed Pharma distributes these products in the Philippines.
• Horphag ResearchcoreOEM/ Whitelabel/ Licensing PartnerGlobal supplier of Pycnogenol (French maritime pine bark extract), a patented ingredient used in Diavision capsules for diabetic retinopathy. Pycnogenol is a registered trademark of Horphag Research. Ophthamed Pharma sources genuine licensed Pycnogenol for their supplement formulations.
• Horphag CorporationcoreOEM/ Whitelabel/ Licensing PartnerLicensor of Mirtogenol, a proprietary blend used in Glaucomin for glaucoma management. Mirtogenol is a registered trademark of Horphag Corporation. Ophthamed Pharma uses only genuine licensed Mirtogenol in their product.
• Eschenbach OptikcoreChannel Partner/ Reseller/ DistributorGerman manufacturer of low vision aids and magnification devices. Ophthamed Pharma distributes Eschenbach Optik products in the Philippines including optical magnifiers and visual rehabilitation equipment for patients with low vision.
• BionikominorChannel Partner/ Reseller/ DistributorManufacturer of ophthalmic surgical simulator models for training purposes. Ophthamed Pharma distributes Bioniko surgical simulation models in the Philippines for ophthalmology training and education.
• OptomedminorChannel Partner/ Reseller/ DistributorFinnish manufacturer of ophthalmic devices including Smartscope Pro. Ophthamed Pharma distributes Optomed products in the Philippines.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Alcon: Alcon is a global leader in eye care, offering surgical and vision care products including ophthalmic pharmaceuticals, intra-ocular lenses, and diagnostic equipment — many of which overlap with Ophthamed's product lines. It is a broad incumbent serving ophthalmologists and optometrists worldwide, including in the Philippines, with much greater scale and R&D depth.
• AbbVie (Allergan Aesthetics): AbbVie, through its Allergan acquisition, holds a leading ophthalmic pharmaceutical portfolio including dry eye, glaucoma, and retinal therapies. It is a broad incumbent that competes with Ophthamed's prescription ophthalmic drops and supplement-adjacent categories across the Philippines and globally.
• Bausch + Lomb: Bausch + Lomb is a major global ophthalmic pharmaceutical and medical device company spanning prescription eye drops, intra-ocular lenses, low vision aids, and contact lens products. It competes broadly with Ophthamed's diversified ophthalmic portfolio and operates across Asia-Pacific through established distribution channels.

Direct peers

• Santen Pharmaceutical: Santen is a Japan-based specialty ophthalmic pharmaceutical company focused on prescription eye care products including glaucoma and dry eye therapeutics. It is a direct peer to Ophthamed in the ophthalmology specialty pharma category and has presence across Asia-Pacific, including distribution in the Philippines.
• Unilab: Unilab is the largest Philippine-owned pharmaceutical company, distributing a broad pharmaceutical and consumer health portfolio across the Philippines. It is the most direct domestic competitor to Ophthamed Pharma in distributing branded FDA-registered products to Filipino physicians and consumers, although Unilab is much larger and more diversified across therapeutic categories.
• Metro Drug: Metro Drug is a major Philippine pharmaceutical distribution and retail pharmacy company with nationwide coverage. It is a direct peer to Ophthamed in the distribution of FDA-registered pharmaceutical products to Filipino consumers and healthcare providers, though its scale and breadth of categories are substantially larger.
• Rohto Pharmaceutical: Rohto is a Japanese ophthalmic pharmaceutical company with a strong Asian presence, including in Southeast Asia, offering branded eye drops and dry eye treatments. It directly competes with Ophthamed in the preservative-free and specialty ophthalmic categories across the Philippines and broader ASEAN.

Others

• Ursapharm: Ursapharm is the German manufacturer of Hylo dry eye care products featuring the patented COMOD multi-dose system. It is Ophthamed's principal supplier rather than a competitor, but represents the underlying technology and brand that anchors Ophthamed's preservative-free dry eye business.
• Horphag Research: Horphag Research is the IP holder and global supplier of Pycnogenol® and Mirtogenol® — key ingredients in Ophthamed's Diavision and Glaucomin supplements. It is an upstream partner rather than a competitor, but is the foundational licensor of Ophthamed's premium supplement differentiation.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/100072315085818
• LinkedInlinkedin.com/company/ophthamed-pharma-corporation

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ophthamed Pharma